Our further studies firstly found that remodelin increased the infiltrated CD8+ T cells, and suppressed the number of Treg and angiogenesis recruitment, which suggested that remodelin may be combined with immunotherapy to inhibit HNSCC progression. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.